CompletedNCT05633108
A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders
Observational studyAges 18+United KingdomSchizophrenia
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- HatfieldSee all locations and recruitment
Study information
Study start dateStarted: March 30, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 579,728
- Sponsor
- Eisai Co., Ltd.
- Sponsor type
- Other organization
- Study type
- Observational
- Intervention type
- OTHER
- Study phase
- Not clearly listed
- Locations
- United Kingdom
- Age range
- Over 18 Years
- Official registry ID
- NCT05633108
- Official title
Show the full official title
A Retrospective Observational Study Based on the French National Health Insurance Database to Describe Antipsychotic Monotherapy and Polypharmacy Use, Including Loxapac, and to Investigate Their Association With Psychiatric Rehospitalization in Patients With Psychotic Disorders
Recruitment & locations
CompletedHatfield
Questions about this study
Who is behind this study?
The study sponsor is Eisai Co., Ltd.
Who was this study for?
Listed age limits: from 18 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me